Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Urinary tract infection? 652 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 652 reports of Urinary tract infection have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.8% of all adverse event reports for DOXORUBICIN.

652
Reports of Urinary tract infection with DOXORUBICIN
0.8%
of all DOXORUBICIN reports
104
Deaths
430
Hospitalizations

How Dangerous Is Urinary tract infection From DOXORUBICIN?

Of the 652 reports, 104 (16.0%) resulted in death, 430 (66.0%) required hospitalization, and 109 (16.7%) were considered life-threatening.

Is Urinary tract infection Listed in the Official Label?

Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for DOXORUBICIN.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which DOXORUBICIN Alternatives Have Lower Urinary tract infection Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection DOXORUBICIN Demographics